Our second flagship journal of 2021 comprises a selection of articles highlighting key advances across a range of therapeutic disciplines including haematology, rheumatology, respiratory medicine, and more. Themes covered in this issue appeal to a broad range of healthcare professionals and include COVID-19, acute myeloid leukaemia, and Ehlers-Danlos Syndrome, among others.
EMJ 6.2 2021
June 2021
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/06/Resp-Interview-Climate-Change-Pollution-and-Respiratory-Health-How-HCPs-Can-Help-Mitigate-the-Risks-web-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/06/Resp-Interview-Role-of-Nebulisers-in-the-Treatment-of-Patients-with-Chronic-Obstructive-Pulmonary-Disease-web-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/06/Innov-Feature-The-Labyrinth-of-Rare-Disease-Diagnosis-web-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2024/06/Innov-Article-Congenital-Heart-Disease-and-Autism-Spectrum-Disorder-web-940x564.jpg)